Omron Corp. (OTCMKTS:OMRNY – Get Free Report) saw a significant drop in short interest in the month of February. As of February 13th, there was short interest totaling 12,759 shares, a drop of 20.9% from the January 29th total of 16,138 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 161,213 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 161,213 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are sold short.
Institutional Trading of Omron
An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC raised its position in Omron Corp. (OTCMKTS:OMRNY – Free Report) by 50.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,129 shares of the company’s stock after buying an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 as of its most recent filing with the Securities and Exchange Commission. 1.09% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Separately, Zacks Research upgraded Omron from a “strong sell” rating to a “hold” rating in a research report on Monday, January 19th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock has an average rating of “Hold”.
Omron Stock Down 8.2%
OTCMKTS OMRNY traded down $2.81 on Tuesday, hitting $31.51. 99,380 shares of the stock were exchanged, compared to its average volume of 45,846. The company has a market cap of $6.50 billion, a PE ratio of 39.89, a PEG ratio of 0.55 and a beta of 0.91. The company has a 50-day moving average price of $27.89 and a 200-day moving average price of $27.13. The company has a quick ratio of 1.37, a current ratio of 2.11 and a debt-to-equity ratio of 0.13. Omron has a fifty-two week low of $23.23 and a fifty-two week high of $35.90.
Omron (OTCMKTS:OMRNY – Get Free Report) last announced its quarterly earnings results on Thursday, February 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.19). Omron had a return on equity of 2.46% and a net margin of 2.80%.The business had revenue of $1.41 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. Sell-side analysts anticipate that Omron will post 0.42 EPS for the current fiscal year.
About Omron
Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.
Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.
Further Reading
- Five stocks we like better than Omron
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.
